Range
- - -
Vol / Avg.
-/0.2K
Div / Yield
-
52 Wk
3.56 - 4.12
Mkt Cap
75.2M
Payout Ratio
-
Open
-
P/E
-
Shares
19.6M
Outstanding
-
Total Float
-
There is no Press for this Ticker
Pharnext SA is a biopharmaceutical company developing treatments targeting neurodegenerative diseases. The company also develop a Pleotherapy technology platform. Its product in the pipeline includes SYNGILITY; PXT3003 and PXT864. The company's only segment being research and development on new pharmaceutical therapies based on Pleotherapy.

Related Companies

TickerCompanyChg %Mkt Cap
PNEXFPharnext0%75.2M

Pharnext Frequently Asked Questions

Q

How do I buy Pharnext (PNEXF) stock?

A

You can purchase shares of Pharnext (OTC: PNEXF) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Pharnext's (PNEXF) competitors?

A

There are no as such competitors for Pharnext.

Q

What is the target price for Pharnext (PNEXF) stock?

A

There is no analysis for Pharnext

Q

Current Stock Price for Pharnext (PNEXF)?

A

The stock price for Pharnext (OTC: PNEXF) is $3.8297 last updated Mon May 17 2021 13:42:51 GMT+0000 (Coordinated Universal Time).

Q

Does Pharnext (PNEXF) pay a dividend?

A

There are no upcoming dividends for Pharnext.

Q

When is Pharnext (OTC:PNEXF) reporting earnings?

A

Pharnext does not have any upcoming earnings scheduled.

Q

Is Pharnext (PNEXF) going to split?

A

There is no upcoming split for Pharnext.

Q

What sector and industry does Pharnext (PNEXF) operate in?

A

Pharnext is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the OTC.